TY - JOUR AU - Liu, D. PY - 2019 DA - 2019// TI - CAR-T "the living drugs", immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy JO - J Hematol Oncol. VL - 12 UR - https://doi.org/10.1186/s13045-019-0819-1 DO - 10.1186/s13045-019-0819-1 ID - Liu2019 ER - TY - JOUR AU - Qiu, Z. AU - Chen, Z. AU - Zhang, C. AU - Zhong, W. PY - 2019 DA - 2019// TI - Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer JO - Exp Hematol Oncol. VL - 8 UR - https://doi.org/10.1186/s40164-019-0143-z DO - 10.1186/s40164-019-0143-z ID - Qiu2019 ER - TY - JOUR AU - Huang, J. AU - Tan, J. AU - Chen, Y. AU - Huang, S. AU - Xu, L. AU - Zhang, Y. PY - 2019 DA - 2019// TI - A skewed distribution and increased PD-1 + Vβ + CD4+/CD8+ T cells in patients with acute myeloid leukemia JO - J Leukoc Biol. VL - 106 UR - https://doi.org/10.1002/JLB.MA0119-021R DO - 10.1002/JLB.MA0119-021R ID - Huang2019 ER - TY - JOUR AU - Stahl, M. AU - Goldberg, A. D. PY - 2019 DA - 2019// TI - Immune checkpoint inhibitors in acute myeloid leukemia: novel combinations and therapeutic targets JO - Curr Oncol Rep. VL - 21 UR - https://doi.org/10.1007/s11912-019-0781-7 DO - 10.1007/s11912-019-0781-7 ID - Stahl2019 ER - TY - JOUR AU - Williams, P. AU - Basu, S. AU - Garcia-Manero, G. AU - Hourigan, C. S. AU - Oetjen, K. A. AU - Cortes, J. E. PY - 2019 DA - 2019// TI - The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia JO - Cancer. VL - 125 UR - https://doi.org/10.1002/cncr.31896 DO - 10.1002/cncr.31896 ID - Williams2019 ER - TY - JOUR AU - Mer, A. S. AU - Lindberg, J. AU - Nilsson, C. AU - Klevebring, D. AU - Wang, M. AU - Grönberg, H. PY - 2018 DA - 2018// TI - Expression levels of long non-coding RNAs are prognostic for AML outcome JO - J Hematol Oncol. VL - 11 UR - https://doi.org/10.1186/s13045-018-0596-2 DO - 10.1186/s13045-018-0596-2 ID - Mer2018 ER - TY - JOUR AU - Smolle, M. A. AU - Prinz, F. AU - Calin, G. A. AU - Pichler, M. PY - 2019 DA - 2019// TI - Current concepts of non-coding RNA regulation of immune checkpoints in cancer JO - Mol Aspects Med. VL - 70 UR - https://doi.org/10.1016/j.mam.2019.09.007 DO - 10.1016/j.mam.2019.09.007 ID - Smolle2019 ER - TY - JOUR AU - Tan, J. AU - Chen, S. AU - Lu, Y. AU - Yao, D. AU - Xu, L. AU - Zhang, Y. PY - 2017 DA - 2017// TI - Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia JO - Chin J Cancer Res. VL - 29 UR - https://doi.org/10.21147/j.issn.1000-9604.2017.05.11 DO - 10.21147/j.issn.1000-9604.2017.05.11 ID - Tan2017 ER - TY - STD TI - Chen Y, Tan J, Huang S, Huang X, Huang J, Chen J, et al. Higher frequency of the CTLA-4+ LAG-3+ T-cell subset in patients with newly diagnosed acute myeloid leukemia. Asia Pac J Clin Oncol. 2019. https://doi.org/10.1111/ajco.13236 [Epub ahead of print]. ID - ref9 ER - TY - JOUR AU - Wu, K. AU - Yi, M. AU - Qin, S. AU - Chu, Q. AU - Zheng, X. AU - Wu, K. PY - 2019 DA - 2019// TI - The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis JO - Exp Hematol Oncol. VL - 8 UR - https://doi.org/10.1186/s40164-019-0150-0 DO - 10.1186/s40164-019-0150-0 ID - Wu2019 ER - TY - JOUR AU - Daver, N. AU - Schlenk, R. F. AU - Russell, N. H. AU - Levis, M. J. PY - 2019 DA - 2019// TI - Targeting FLT3 mutations in AML: review of current knowledge and evidence JO - Leukemia. VL - 33 UR - https://doi.org/10.1038/s41375-018-0357-9 DO - 10.1038/s41375-018-0357-9 ID - Daver2019 ER - TY - JOUR AU - Gu, R. AU - Yang, X. AU - Wei, H. PY - 2018 DA - 2018// TI - Molecular landscape and targeted therapy of acute myeloid leukemia JO - Biomark Res. VL - 6 UR - https://doi.org/10.1186/s40364-018-0146-7 DO - 10.1186/s40364-018-0146-7 ID - Gu2018 ER - TY - JOUR AU - Zhao, J. AU - Song, Y. AU - Liu, D. PY - 2019 DA - 2019// TI - Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia JO - Biomark Res. VL - 7 UR - https://doi.org/10.1186/s40364-019-0170-2 DO - 10.1186/s40364-019-0170-2 ID - Zhao2019 ER -